National Cancer Institute Amended; Notice of Meeting
---
identifier: "/us/fr/2019-11954"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Cancer Institute Amended; Notice of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2019-11954"
section_name: "National Cancer Institute Amended; Notice of Meeting"
positive_law: false
currency: "2019-06-07"
last_updated: "2019-06-07"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2019-11954"
document_type: "notice"
publication_date: "2019-06-07"
agencies:
- "Health and Human Services Department"
- "National Institutes of Health"
fr_citation: "84 FR 26691"
fr_volume: 84
---
# National Cancer Institute Amended; Notice of Meeting
Notice is hereby given of a change in the meeting of the National Cancer Institute Special Emphasis Panel, July 17, 2019, 08:00 a.m. to 05:00 p.m., Hilton Washington/Rockville Hotel, 1750 Rockville Pike, Rockville, MD 08852 which was published in the *Federal Register* on May 13, 2019, 84 FR 20900.
This meeting notice is amended to change the name of the meeting from Advancing Cancer Immunotherapy by Mitigating-Immune related adverse events to Advancing Cancer Immunotherapy by Mitigating irAEs. The meeting is closed to the public.
Dated: June 3, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.